Breaking News Instant updates and real-time market news.

KBH

KB Home

$43.67 /

+0.42 (+0.97%)

14:49
06/23/21
06/23
14:49
06/23/21
14:49

KB Home options imply 9.9% move in share price post-earnings

Pre-earnings options volume in KB Home is 10.8x normal with calls leading puts 8:3. Implied volatility suggests the market is anticipating a move near 9.9%, or $4.30, after results are released. Median move over the past eight quarters is 4.6%.

  • 23

    Jun

KBH KB Home
$43.67 /

+0.42 (+0.97%)

06/15/21 Wedbush
Wedbush sees pullback in KB Home shares as buying opportunity
04/15/21 Wells Fargo
KB Home initiated with an Overweight at Wells Fargo
03/29/21 Argus
KB Home's new orders were 'stellar', says Argus
03/25/21 Keefe Bruyette
KB Home price target raised to $48 from $44 at Keefe Bruyette

TODAY'S FREE FLY STORIES

Earnings
Corteva raises FY21 operating EPS view to $2.00-$2.10 from $1.85-$1.95 » 17:04
08/05/21
08/05
17:04
08/05/21
17:04
CTVA

Corteva

$41.44 /

-0.87 (-2.06%)

FY21 consensus $1.93.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTVA Corteva
$41.44 /

-0.87 (-2.06%)

CTVA Corteva
$41.44 /

-0.87 (-2.06%)

06/24/21 Deutsche Bank
Corteva shares could rise 50% by end of 2023, says Deutsche Bank
05/26/21 JPMorgan
Corteva shares have been 'over-penalized,' says JPMorgan
05/17/21 Argus
Corteva price target raised to $54 from $51 at Argus
05/10/21 BofA
Corteva double downgraded to Underperform at BofA on litigation risks
CTVA Corteva
$41.44 /

-0.87 (-2.06%)

CTVA Corteva
$41.44 /

-0.87 (-2.06%)

Earnings
El Pollo Loco reports Q2 EPS 29c, consensus 27c » 17:03
08/05/21
08/05
17:03
08/05/21
17:03
LOCO

El Pollo Loco

$18.30 /

+0.145 (+0.80%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LOCO El Pollo Loco
$18.30 /

+0.145 (+0.80%)

LOCO El Pollo Loco
$18.30 /

+0.145 (+0.80%)

02/08/21 Truist
El Pollo Loco downgraded to Hold from Buy at Truist
02/08/21 Truist
El Pollo Loco downgraded to Hold from Buy at Truist
LOCO El Pollo Loco
$18.30 /

+0.145 (+0.80%)

Earnings
Golden Entertainment reports Q2 EPS $3.26, consensus 49c » 17:03
08/05/21
08/05
17:03
08/05/21
17:03
GDEN

Golden Entertainment

$47.31 /

+2.67 (+5.98%)

Reports Q2 revenue $292M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GDEN Golden Entertainment
$47.31 /

+2.67 (+5.98%)

05/07/21 B. Riley
Golden Entertainment price target raised to $60 from $48 at B. Riley
05/07/21 Deutsche Bank
Golden Entertainment price target raised to $42 from $34 at Deutsche Bank
05/07/21 Macquarie
Golden Entertainment price target raised to $50 from $43 at Macquarie
04/27/21 B. Riley
Golden Entertainment initiated with a Buy at B. Riley
GDEN Golden Entertainment
$47.31 /

+2.67 (+5.98%)

GDEN Golden Entertainment
$47.31 /

+2.67 (+5.98%)

Earnings
Chembio Diagnostics reports Q2 EPS (45c), consensus (27c) » 17:02
08/05/21
08/05
17:02
08/05/21
17:02
CEMI

Chembio Diagnostics

$3.52 /

+0.105 (+3.08%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CEMI Chembio Diagnostics
$3.52 /

+0.105 (+3.08%)

CEMI Chembio Diagnostics
$3.52 /

+0.105 (+3.08%)

07/22/21 Benchmark
Chembio's Ethiopia order factored in estimates, says Benchmark
07/21/21 Colliers
Colliers downgrades Chembio Diagnostics, says current price 'too aggressive'
07/21/21 Colliers
Chembio Diagnostics downgraded to Neutral from Buy at Colliers
12/03/20 Craig-Hallum
Chembio Diagnostics upgraded to Buy at Craig-Hallum
CEMI Chembio Diagnostics
$3.52 /

+0.105 (+3.08%)

CEMI Chembio Diagnostics
$3.52 /

+0.105 (+3.08%)

CEMI Chembio Diagnostics
$3.52 /

+0.105 (+3.08%)

Earnings
ITT raises FY21 adjusted EPS view to $3.90-$4.05 from $3.80-$4.00  17:02
08/05/21
08/05
17:02
08/05/21
17:02
ITT

ITT

$97.96 /

+0.89 (+0.92%)

Consensus $3.97.

ShowHide Related Items >><<
ITT ITT
$97.96 /

+0.89 (+0.92%)

ITT ITT
$97.96 /

+0.89 (+0.92%)

06/15/21 Citi
ITT initiated with a Buy at Citi
05/13/21 Gordon Haskett
Gordon Haskett downgrades ITT on valuation, high expectations
05/13/21 Gordon Haskett
ITT downgraded to Hold from Buy at Gordon Haskett
05/10/21 UBS
ITT downgraded to Neutral from Buy on valuation at UBS
ITT ITT
$97.96 /

+0.89 (+0.92%)

Earnings
BigCommerce sees FY21 revenue 210.7M-$211.7M, consensus $197.67M  17:02
08/05/21
08/05
17:02
08/05/21
17:02
BIGC

BigCommerce

$71.36 /

+2.16 (+3.12%)

 
ShowHide Related Items >><<
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

07/28/21 Needham
BigCommerce price target raised to $85 from $60 at Needham
07/23/21 Barclays
BigCommerce price target raised to $66 from $53 at Barclays
07/20/21 William Blair
New partnerships align with BigCommerce open SaaS strategy, says William Blair
07/07/21 Piper Sandler
Piper says integration with Amazon MFC strengthens BigCommerce bull case
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

  • 13
    Nov
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

Earnings
Corteva reports Q2 adjusted EPS $1.40, consensus $1.26 » 17:02
08/05/21
08/05
17:02
08/05/21
17:02
CTVA

Corteva

$41.44 /

-0.87 (-2.06%)

Reports Q2 revenue $5.6B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTVA Corteva
$41.44 /

-0.87 (-2.06%)

CTVA Corteva
$41.44 /

-0.87 (-2.06%)

06/24/21 Deutsche Bank
Corteva shares could rise 50% by end of 2023, says Deutsche Bank
05/26/21 JPMorgan
Corteva shares have been 'over-penalized,' says JPMorgan
05/17/21 Argus
Corteva price target raised to $54 from $51 at Argus
05/10/21 BofA
Corteva double downgraded to Underperform at BofA on litigation risks
CTVA Corteva
$41.44 /

-0.87 (-2.06%)

CTVA Corteva
$41.44 /

-0.87 (-2.06%)

Earnings
ITT reports Q2 adjusted EPS 94c, consensus 90c » 17:02
08/05/21
08/05
17:02
08/05/21
17:02
ITT

ITT

$97.96 /

+0.89 (+0.92%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITT ITT
$97.96 /

+0.89 (+0.92%)

ITT ITT
$97.96 /

+0.89 (+0.92%)

06/15/21 Citi
ITT initiated with a Buy at Citi
05/13/21 Gordon Haskett
Gordon Haskett downgrades ITT on valuation, high expectations
05/13/21 Gordon Haskett
ITT downgraded to Hold from Buy at Gordon Haskett
05/10/21 UBS
ITT downgraded to Neutral from Buy on valuation at UBS
ITT ITT
$97.96 /

+0.89 (+0.92%)

Earnings
BigCommerce Sees Q3 revenue $ $54.5M-$55M, consensus $49.88M  17:01
08/05/21
08/05
17:01
08/05/21
17:01
BIGC

BigCommerce

$71.36 /

+2.16 (+3.12%)

 
ShowHide Related Items >><<
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

07/28/21 Needham
BigCommerce price target raised to $85 from $60 at Needham
07/23/21 Barclays
BigCommerce price target raised to $66 from $53 at Barclays
07/20/21 William Blair
New partnerships align with BigCommerce open SaaS strategy, says William Blair
07/07/21 Piper Sandler
Piper says integration with Amazon MFC strengthens BigCommerce bull case
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

  • 13
    Nov
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

Earnings
Arcutis Biotherapeutics reports Q2 EPS (84c), consensus (90c) » 17:00
08/05/21
08/05
17:00
08/05/21
17:00
ARQT

Arcutis Biotherapeutics

$21.74 /

+0.89 (+4.27%)

Cash, cash equivalents,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

06/29/21 Mizuho
Arcutis Biotherapeutics initiated with a Buy at Mizuho
05/27/21 Morgan Stanley
Arcutis Biotherapeutics initiated with an Overweight at Morgan Stanley
02/02/21 Truist
Arcutis Biotherapeutics price target raised to $48 from $38 at Truist
02/01/21 Cowen
Arcutis Biotherapeutics price target raised to $80 from $55 at Cowen
ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

  • 03
    Feb
  • 02
    Oct
ARQT Arcutis Biotherapeutics
$21.74 /

+0.89 (+4.27%)

Earnings
MP Materials reports Q2 EPS 15c, consensus 13c » 17:00
08/05/21
08/05
17:00
08/05/21
17:00
MP

MP Materials

$36.10 /

+0.48 (+1.35%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MP MP Materials
$36.10 /

+0.48 (+1.35%)

MP MP Materials
$36.10 /

+0.48 (+1.35%)

07/23/21
Fly Intel: Top five analyst initiations
07/23/21 DA Davidson
MP Materials initiated with a Buy at DA Davidson
06/29/21 Baird
Baird starts MP Materials at Outperform, sees 'superior multiple' warranted
06/29/21 Baird
MP Materials initiated with an Outperform at Baird
MP MP Materials
$36.10 /

+0.48 (+1.35%)

  • 24
    Mar
MP MP Materials
$36.10 /

+0.48 (+1.35%)

MP MP Materials
$36.10 /

+0.48 (+1.35%)

MP MP Materials
$36.10 /

+0.48 (+1.35%)

Earnings
B&G Foods backs FY21 revenue view of $2.05B-$2.10B, consensus $2.16B » 17:00
08/05/21
08/05
17:00
08/05/21
17:00
BGS

B&G Foods

$28.18 /

+0.19 (+0.68%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

03/22/21
Fly Intel: Top five analyst downgrades
03/22/21 Piper Sandler
B&G Foods downgraded to Neutral from Overweight at Piper Sandler
03/03/21 RBC Capital
B&G Foods price target lowered to $29 from $32 at RBC Capital
01/19/21 Stephens
B&G Foods initiated with an Equal Weight at Stephens
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

Earnings
Livent raises FY21 revenue view to $370M-$390M from $335M-$365M » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
LTHM

Livent

$20.38 /

+1.19 (+6.20%)

Consensus for FY21…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LTHM Livent
$20.38 /

+1.19 (+6.20%)

04/19/21
Fly Intel: Top five analyst upgrades
04/19/21 Evercore ISI
Evercore 'all in on lithium producers,' upgrades Livent to Outperform
04/19/21 Evercore ISI
Livent upgraded to Outperform from In Line at Evercore ISI
03/15/21 Credit Suisse
Livent assumed with a Neutral at Credit Suisse
LTHM Livent
$20.38 /

+1.19 (+6.20%)

  • 11
    Jun
LTHM Livent
$20.38 /

+1.19 (+6.20%)

Earnings
B&G Foods reports Q2 EPS 41c, consensus 49c » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
BGS

B&G Foods

$28.18 /

+0.19 (+0.68%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

03/22/21
Fly Intel: Top five analyst downgrades
03/22/21 Piper Sandler
B&G Foods downgraded to Neutral from Overweight at Piper Sandler
03/03/21 RBC Capital
B&G Foods price target lowered to $29 from $32 at RBC Capital
01/19/21 Stephens
B&G Foods initiated with an Equal Weight at Stephens
BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

BGS B&G Foods
$28.18 /

+0.19 (+0.68%)

Earnings
BigCommerce reports Q2 EPS (6c), consensus (11c) » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
BIGC

BigCommerce

$71.36 /

+2.16 (+3.12%)

Reports Q revenue $49M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

07/28/21 Needham
BigCommerce price target raised to $85 from $60 at Needham
07/23/21 Barclays
BigCommerce price target raised to $66 from $53 at Barclays
07/20/21 William Blair
New partnerships align with BigCommerce open SaaS strategy, says William Blair
07/07/21 Piper Sandler
Piper says integration with Amazon MFC strengthens BigCommerce bull case
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

  • 13
    Nov
BIGC BigCommerce
$71.36 /

+2.16 (+3.12%)

Earnings
Magnite reports Q2 adjusted EPS 11c, consensus 12c » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
MGNI

Magnite

$30.70 /

+1.08 (+3.65%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

07/13/21 Stifel
Tremor International initiated with a Buy at Stifel
07/02/21 Craig-Hallum
Craig-Hallum says Magnite SpringServe deal more consequential than price implies
06/25/21 Macquarie
Google cookie delay removes near-term overhang on adtech, says Macquarie
06/11/21 Stephens
Magnite partnerships can help accelerate shift in spend to CTV, says Stephens
MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

MGNI Magnite
$30.70 /

+1.08 (+3.65%)

Hot Stocks
Appian acquires Lana Labs, terms not disclosed » 16:59
08/05/21
08/05
16:59
08/05/21
16:59
APPN

Appian

$111.98 /

+2.22 (+2.02%)

Appian announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APPN Appian
$111.98 /

+2.22 (+2.02%)

08/02/21 Truist
Appian price target lowered to $120 from $205 at Truist
05/25/21
Fly Intel: Top five analyst upgrades
05/25/21 Macquarie
Appian upgraded to Neutral after share correction at Macquarie
05/25/21 Macquarie
Appian upgraded to Neutral from Underperform at Macquarie
APPN Appian
$111.98 /

+2.22 (+2.02%)

Hot Stocks
Covetrus backs FY21 adjusted EBITDA view of $245M-$255M  16:58
08/05/21
08/05
16:58
08/05/21
16:58
CVET

Covetrus

$25.41 /

+0.475 (+1.90%)

 
ShowHide Related Items >><<
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

CVET Covetrus
$25.41 /

+0.475 (+1.90%)

08/04/21 Credit Suisse
Covetrus assumed with a Neutral at Credit Suisse
07/12/21 Guggenheim
Covetrus upgraded to Buy from Neutral at Guggenheim
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Barclays
Covetrus initiated with an Overweight at Barclays
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

Hot Stocks
Air Transport Services sees FY21 CapEx $550M » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
ATSG

Air Transport Services

$25.42 /

+0.53 (+2.13%)

The company said:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

06/21/21 Stifel
Air Transport Services resumed with a Buy at Stifel
10/12/20 Loop Capital
Air Transport Services upgraded to Buy from Hold at Loop Capital
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

Earnings
Livent reports Q2 adjusted EPS 4c, consensus 2c » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
LTHM

Livent

$20.38 /

+1.19 (+6.20%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LTHM Livent
$20.38 /

+1.19 (+6.20%)

04/19/21
Fly Intel: Top five analyst upgrades
04/19/21 Evercore ISI
Evercore 'all in on lithium producers,' upgrades Livent to Outperform
04/19/21 Evercore ISI
Livent upgraded to Outperform from In Line at Evercore ISI
03/15/21 Credit Suisse
Livent assumed with a Neutral at Credit Suisse
LTHM Livent
$20.38 /

+1.19 (+6.20%)

  • 11
    Jun
LTHM Livent
$20.38 /

+1.19 (+6.20%)

Earnings
Covetrus reports Q2 adjusted EBITDA $66M vs. $63M last year » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
CVET

Covetrus

$25.41 /

+0.475 (+1.90%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

CVET Covetrus
$25.41 /

+0.475 (+1.90%)

08/04/21 Credit Suisse
Covetrus assumed with a Neutral at Credit Suisse
07/12/21 Guggenheim
Covetrus upgraded to Buy from Neutral at Guggenheim
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Barclays
Covetrus initiated with an Overweight at Barclays
CVET Covetrus
$25.41 /

+0.475 (+1.90%)

Earnings
Air Transport Services reports Q2 adjusted EPS 35c, consensus 27c » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
ATSG

Air Transport Services

$25.42 /

+0.53 (+2.13%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

06/21/21 Stifel
Air Transport Services resumed with a Buy at Stifel
10/12/20 Loop Capital
Air Transport Services upgraded to Buy from Hold at Loop Capital
ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

ATSG Air Transport Services
$25.42 /

+0.53 (+2.13%)

Hot Stocks
MEI Pharma CFO Brian Drazba to retire at end of 2021 » 16:58
08/05/21
08/05
16:58
08/05/21
16:58
MEIP

MEI Pharma

$2.66 /

+0.04 (+1.53%)

MEI Pharma announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEIP MEI Pharma
$2.66 /

+0.04 (+1.53%)

MEIP MEI Pharma
$2.66 /

+0.04 (+1.53%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
MEIP MEI Pharma
$2.66 /

+0.04 (+1.53%)

Earnings
Aligos Therapeutics reports Q2 EPS (79c), consensus (81c) » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ALGS

Aligos Therapeutics

$16.31 /

+0.85 (+5.50%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

07/08/21 Piper Sandler
Aligos should be bought into 'catalyst rich' second half, says Piper Sandler
06/21/21 Piper Sandler
Aligos reported 'robust data' in hepatitis B virus, says Piper Sandler
06/10/21 Piper Sandler
Aligos Therapeutics has data-rich month with robust lineup, says Piper Sandler
05/17/21 Piper Sandler
Aligos Therapeutics assumed with an Overweight at Piper Sandler
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

  • 01
    Jul
  • 16
    Oct
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

Earnings
Aligos Therapeutics reports Q2 EPS (79c), consensus (81c) » 16:57
08/05/21
08/05
16:57
08/05/21
16:57
ALGS

Aligos Therapeutics

$16.31 /

+0.85 (+5.50%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

07/08/21 Piper Sandler
Aligos should be bought into 'catalyst rich' second half, says Piper Sandler
06/21/21 Piper Sandler
Aligos reported 'robust data' in hepatitis B virus, says Piper Sandler
06/10/21 Piper Sandler
Aligos Therapeutics has data-rich month with robust lineup, says Piper Sandler
05/17/21 Piper Sandler
Aligos Therapeutics assumed with an Overweight at Piper Sandler
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

  • 01
    Jul
  • 16
    Oct
ALGS Aligos Therapeutics
$16.31 /

+0.85 (+5.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.